This is a special type of heart test using a radioactive dye. The dye is injected into the heart, and pictures are taken as it flows through the ventricles. This test helps doctors see how well the heart's lower chambers are pumping blood. It's a way to check heart function.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
First-pass ventriculography, also called first-pass radionuclide angiography, is a nuclear medicine heart test. A small, tightly packed dose of a radioactive tracer is injected into a vein, and a special camera called a gamma camera records it during its first trip through the heart's chambers, before it mixes evenly into the blood. Because the tracer reaches the right side of the heart before the left, each pumping chamber (ventricle) can be measured separately. The test's main use today is measuring how well the right ventricle pumps. The result is usually given as an ejection fraction: the share of blood the chamber squeezes out with each beat. A related nuclear test, the gated blood-pool or multigated acquisition (MUGA) scan, is better suited to the left ventricle and cannot reliably measure the right, so many centers do both in one visit. First-pass imaging is often requested for people with advanced heart failure who are being considered for a left ventricular assist device (a surgically implanted heart pump) or a transplant, because failure of the right ventricle after that surgery is a serious concern. A version of the same technique tracks the tracer through the heart and lungs to measure a left-to-right shunt, an abnormal opening such as a hole between heart chambers that sends extra blood back to the lungs. It is used to size a shunt already found on an echocardiogram (heart ultrasound) and to check it after treatment. Echocardiography is usually the first test for heart function. Cardiac magnetic resonance imaging (MRI) is considered the most accurate way to measure the right ventricle, but it is not available everywhere and an implanted defibrillator or pacemaker can make it harder or impossible. First-pass imaging fills that gap.
A resting first-pass study needs no special preparation, and fasting is not usually required. If exercise or a stress medicine will be added to the test, the team may ask you to stop eating a few hours beforehand and to hold certain heart medicines, so follow the center's instructions. Tell the team if you are pregnant or might be. The tracer exposes the body to radiation and can reach the baby, so an echocardiogram or MRI is generally preferred during pregnancy. If you are breastfeeding, ask how long to pause: the tracer passes into breast milk, and guidance commonly ranges from about 12 to 24 hours, and the label for one tracer kit advises switching to formula for that time. You may also be asked to remove jewelry or metal near the chest.
You lie on a table, usually on your back, with the camera close to your chest. A small tube is placed in a vein, typically in the arm. In many heart-function studies, a few milliliters of your blood are drawn first, mixed with the tracer in the laboratory so it attaches to your red blood cells, and then returned to you. For a shunt study, the tracer is injected directly. The tracer is pushed in quickly and followed by a flush of salt water so it travels as one compact bolus. The camera then records rapid images as it passes through the heart. This first-pass recording lasts well under a minute, so lying still and breathing normally matter, because straining or holding your breath can disrupt the bolus. If gated blood-pool imaging follows, it adds roughly ten minutes or more of imaging. The injection is the only part most people feel.
There is no sedation and no recovery period. Most people go back to normal activities right away. Drinking fluids may help the body clear the tracer. If you are breastfeeding, keep to the pause your team advised. A nuclear medicine physician or cardiologist reviews the images and sends the report to the clinician who ordered the test. For a heart-function study, the report gives the ejection fraction of each ventricle. A left ventricular ejection fraction of 50% or more is generally considered normal; for the right ventricle, a value below about 40% is usually regarded as reduced, although that cutoff is less firmly established. For a shunt study, the report gives the ratio of blood flowing through the lungs to blood flowing to the body (written Qp/Qs). A ratio of 1.5 means the lungs are receiving one and a half times their normal share. Your clinician will interpret the number alongside echocardiogram and other results.
The test is considered low risk. The radiation dose is small, and the drug label for the red blood cell tracer kit lists no known adverse reactions. The main safety considerations are pregnancy and breastfeeding, covered above. The larger limitation is accuracy. Results depend on a clean, compact injection; a broken-up bolus, crying in a young child or straining during the recording can make the numbers unreliable, and the test may need to be repeated. In one small study comparing tests in heart failure patients, right ventricular ejection fraction from first-pass imaging agreed only moderately with cardiac MRI, while the left ventricular measurement agreed closely. Another study found first-pass right ventricle measurements did not predict which people would develop right heart failure after a heart pump was implanted. Shunt measurements are most reliable in the middle range; very small shunts can be falsely detected and very large ones overestimated. For these reasons, the result is usually weighed with echocardiography, catheter pressure measurements or MRI rather than used alone.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with First-Pass Ventriculography, what to expect, or ask the community a question.